D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy

BACKGROUND: Patients with locally advanced resectable gastric cancers are increasingly offered neoadjuvant chemotherapy (NACT) following the MAGIC and REAL-2 trials. However, information on the toxicity of NACT, its effects on perioperative surgical outcomes and tumor response is not widely reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrikhande, Shailesh V, Barreto, Savio G, Talole, Sanjay D, Vinchurkar, Kumar, Annaiah, Somashekar, Suradkar, Kunal, Mehta, Shaesta, Goel, Mahesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583696/
https://www.ncbi.nlm.nih.gov/pubmed/23375104
http://dx.doi.org/10.1186/1477-7819-11-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583696/
https://www.ncbi.nlm.nih.gov/pubmed/23375104
http://dx.doi.org/10.1186/1477-7819-11-31

Ejemplares similares